EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori ‐Infected Peptic Ulcer Children in Vietnam

Thi Minh Phuong Do iD, Thi Huyen Trang Tran, Van Tinh Nguyen, Thi Phuong Mai Chu, Loi Nguyen, Kim Thanh Nguyen, Thi Bich Ngoc Hoang, Anh Le Huu Phuong, Yoshio Yamaoka iD, Linus Olson, Thi Viet Ha Nguyen

Helicobacter · 2024

DOI: 10.1111/hel.13149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Helicobacter, 2024. Verfasst von Thi Minh Phuong Do und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hanoi Medical University, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Helicobacter Infections, Bismuth, Peptic Ulcer, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: the Ministry of Science and Technology of Vietnam - MOST (NĐT.83.GB/20)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The continuous increase in drug‐resistant strains, the lack of novel antibiotics, and the fewer options available to combat antibiotic‐resistant infections in pediatrics pose significant challenges to the eradication of Helicobacter pylori (H. pylori) in children. This study evaluated the efficacy of first‐line therapy with bismuth quadruple therapy in H. pylori ‐positive pediatric patients with peptic ulcers. Materials and Methods 136 patients (aged between 8 and 17 years) diagnosed with active peptic ulcers with H. pylori infection were enrolled in this study. Patients with H. pylori strain sensitive to tetracycline and metronidazole were assigned to bismuth quadruple therapy, including a proton pump inhibitor (PPI), bismuth, tetracycline, and metronidazole. Antibiotic resistance of H. pylori was analyzed by the Epsilometer test. Treatment efficacy was evaluated at 12 weeks based on H. pylori eradication and peptic ulcer healing rates. H. pylori infection status was evaluated by a 13 C‐urea breath test.

Results

Most isolates showed extremely high rates of resistance to commonly prescribed antibiotics used for children, including clarithromycin (97.0%) and amoxicillin (84.6%), while the low rate of resistance to levofloxacin (16.2%). The overall success rate of eradication therapy in the intention‐to‐treat and the per‐protocol group were 86.0% and 89.3%, respectively. Peptic ulcer healing rates for total patients at 6 weeks and 12 weeks were 75.0% and 97.7%, respectively. There were no entail unpleasant adverse events, and peptic ulcer symptoms decreased steadily over time in all cases.

Conclusions

The bismuth quadruple therapy with a 2‐week PPI pretreatment and followed by prolonged PPI was highly successful in eradicating H. pylori infection and healing ulcers in pediatric patients with active peptic ulcer. This might be preferable as a first‐line empiric treatment regimen for H. pylori ‐positive pediatric patients with peptic ulcers, especially in populations with high rates of resistance to amoxicillin and clarithromycin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsBismuthPeptic UlcerAnti-Bacterial AgentsHelicobacter pyloriDrug Therapy, CombinationHumansChildAdolescentMaleFemaleTreatment OutcomeVietnamProton Pump InhibitorsMetronidazoleTetracyclineDrug Resistance, Bacterial

Stichwörter der Autor:innen

Helicobacter pylori eradicationantibiotic resistancebismuth quadruple therapychildrenpeptic ulcers

Substanzen

BismuthAnti-Bacterial AgentsProton Pump InhibitorsMetronidazoleTetracycline

Autor:innen und Institutionen

  • Department of Pediatrics, Hanoi Medical University, Hanoi, Vietnam.
  • Department of Gastroenterology, National Children's Hospital, Hanoi, Vietnam.
  • Center for Stem Cell Research and Application, 108 Hospital, Hanoi, Vietnam.
  • The Vietnamese-German Center for Medical Research (VG-CARE), Vietnam.
  • Department of Microbiology, National Children's Hospital, Hanoi, Vietnam.
  • Department of Environmental and Preventive Medicine, OIta University Faculty of Medicine, Yufu, Japan.

ORCID-Profile: Thi Minh Phuong Do, Yoshio Yamaoka

Förderung

  • the Ministry of Science and Technology of Vietnam - MOST (NĐT.83.GB/20).

Zitieren

APA

Do, T. M. P., Tran, T. H. T., Nguyen, V. T., Chu, T. P. M., Nguyen, L., Nguyen, K. T., Hoang, T. B. N., Phuong, A. L. H., Yamaoka, Y., Olson, L., & Nguyen, T. V. H. (2024). Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori ‐Infected Peptic Ulcer Children in Vietnam. Helicobacter. https://doi.org/10.1111/hel.13149

Vancouver

Do TMP, Tran THT, Nguyen VT, Chu TPM, Nguyen L, Nguyen KT, et al. Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori ‐Infected Peptic Ulcer Children in Vietnam. Helicobacter. 2024. doi:10.1111/hel.13149

BibTeX
@article{Do2024,
  author = {Do, Thi Minh Phuong and Tran, Thi Huyen Trang and Nguyen, Van Tinh and Chu, Thi Phuong Mai and Nguyen, Loi and Nguyen, Kim Thanh and Hoang, Thi Bich Ngoc and Phuong, Anh Le Huu and Yamaoka, Yoshio and Olson, Linus and Nguyen, Thi Viet Ha},
  title = {Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori ‐Infected Peptic Ulcer Children in Vietnam},
  journal = {Helicobacter},
  year = {2024},
  doi = {10.1111/hel.13149}
}
Kostenlos starten →